UPDATE : Saturday, March 28, 2020
상단여백
Multinational drugmakers sweep local sales in Q3
Multinational pharmaceutical companies have swept the local sales in the th...
by So Jae-hyeon  |  2017-12-04 16:08
라인
SNUBH first to prove non-invasive test works for glaucoma patients
Researchers at Seoul National University Bundang Hospital (SNUBH) have prov...
by Marian Chu  |  2017-12-04 14:58
라인
Pfizer taps Kim Sun-a to lead Essential Health division in Japan
Pfizer has elected Kim Sun-A to head Pfizer’s Essential Health division in ...
by Marian Chu  |  2017-12-04 12:14
라인
Pfizer Korea’s sales dwindle in generic drug market
Pfizer Korea’s sales power is dwindling in the local generic drug market, a...
by So Jae-hyeon  |  2017-12-04 11:55
라인
4 drugs gain insurance coverage this month
Four pharmaceuticals said Friday their drugs would gain national coverage, ...
by Marian Chu  |  2017-12-01 17:54
라인
Sanofi faces safety issues with dengue vaccine, will reel back usage
Sanofi said Thursday its dengue vaccine might worsen the disease for those ...
by Marian Chu  |  2017-12-01 14:03
라인
Korea United wins patent suit against Daewoong
Korea United Pharmaceutical has won a patent lawsuit against Daewoong Pharm...
by So Jae-hyeon  |  2017-12-01 14:03
라인
Lung cancer therapy Tagrisso’s price cut by 96%
Lung cancer patients will be able to purchase Tagrisso at 340,000 won ($312...
by Marian Chu  |  2017-12-01 11:19
라인
Sexual scandal at Pfizer Korea belatedly uncovered 
After hospitals came under fire for senior physicians’ sexual violence agai...
by Nam Doo-hyun  |  2017-11-30 16:29
라인
‘Treatment of atopic dermatitis enhances kids’ mental health’
A U.S. dermatology physician said atopic dermatitis treatments could affect...
by Park Gi-taek  |  2017-11-30 16:22
라인
Pfizer Korea’s arthritis treatment gets insurance benefits
Pfizer Korea said Thursday that its nonsteroidal anti-inflammatory drug (NS...
by Constance Williams  |  2017-11-30 11:03
라인
Nanomedicine market to grow rapidly: report
With researchers actively using nanotechnology to treat diseases, the nanom...
by Nam Doo-hyun  |  2017-11-29 16:47
라인
Takeda gets extension for marketing Lymphoma treatment
Takeda Pharmaceuticals Korea announced Tuesday that the European Medicines ...
by Constance Williams  |  2017-11-29 14:58
라인
Novartis Korea mired in sexual harassment scandal
Novartis Korea has been embroiled in a sexual harassment scandal, as a male...
by Park Gi-taek  |  2017-11-29 14:58
라인
GL PharmTech eyes on new drug development, production
GL PharmTech, a provider of drug formulations and delivery technologies for...
by So Jae-hyeon  |  2017-11-29 11:55
라인
Pneumonia added to adverse reactions of hepatitis B drug Viread
The government has received reports of adverse drug reactions, including pn...
by Lee Hye-seon  |  2017-11-28 16:07
라인
Sanofi begins clinical trial on Hanmi’s diabetes treatment
Hanmi Pharmaceutical said Tuesday that Sanofi would begin to conduct phase ...
by Lee Han-soo  |  2017-11-28 11:05
라인
Ministry renews ‘innovative’ certification for 3 pharmaceuticals
The Ministry of Health and Welfare said it has recertified three pharmaceut...
by Marian Chu  |  2017-11-27 14:59
라인
AbbVie to present phase 3 study on investigational leukemia drug
AbbVie said Thursday that the American Society of Hematology (ASH) accepted...
by Marian Chu  |  2017-11-27 12:14
라인
Celltrion joins local drugmakers to tap US generic market
Korea’s generic drug manufacturers are entering the U.S. pharmaceutical mar...
by So Jae-hyeon  |  2017-11-27 12:04
-이전81828384858687888990-
여백
Fully cured patients exceed those under treatment in KoreaFully cured patients exceed those under treatment in Korea
여백
Most viewed
여백
Opinion
[Column] Are we ready for COVID-19’s arrival at schools?
[Column] Are we ready for COVID-19’s arrival at schools?
[Column] Temporary nod for telemedicine against COVID-19 too hasty 
[Column] Temporary nod for telemedicine against COVID-19 too hasty 
[Column] Will ‘third wave’ of COVID-19 hit Korea?
[Column] Will ‘third wave’ of COVID-19 hit Korea?
여백
Back to Top